Results 61 to 70 of about 3,779 (178)

Analysis of the Degree of Information of Dental Surgeons about Antiresorptive Drugs According to the Time Since Graduation in Dentistry

open access: yesPesquisa Brasileira em Odontopediatria e Clínica Integrada, 2023
Objective: To determine the level of scientific information of dental surgeons who carry out their professional activities in Brazil about antiresorptive drugs and indicated pharmacological procedures aiming at the prevention of osteonecrosis of the jaws
Flávia Godinho Costa Wanderley Rocha   +1 more
doaj  

Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates

open access: yesClinical Interventions in Aging, 2016
Tao Gu,1 Debra F Eisenberg Lawrence,1 Judith J Stephenson,1 Jingbo Yu2 1HealthCore, Wilmington, DE, 2Merck & Co., Inc., Kenilworth, NJ, USA Background: Noncompliance with bisphosphonate therapy among osteoporosis patients attenuates the reduction ...
Gu T   +3 more
doaj  

Renal secretion of diphosphonates in rats

open access: yesKidney International, 1975
Diphosphonates, characterized by a P--C--P bond, are relatively new experimental drugs used for the treatment of myositis ossificans, dental calculus, nephrolithiasis and Paget's disease. These compounds are not metabolized and the fraction which is not taken up by the skeleton is excreted unchanged in the urine.
Troehler, Ulrich   +2 more
openaire   +2 more sources

Amiloidosi da transtiretina (ATTR): l’altra faccia della medaglia

open access: yesGiornale di Clinica Nefrologia e Dialisi, 2019
Transthyretin amyloidosis (ATTR) is becoming an emerging clinical entity, and is currently the most common form of systemic amyloidosis. ATTR consists of two distinct diseases depending on whether the amyloid fibrils derive from the intact molecule of ...
Federico Perfetto   +7 more
doaj   +1 more source

Response of a co-culture model of epithelial cells and gingival fibroblasts to zoledronic acid

open access: yesBrazilian Oral Research
Osteonecrosis of the jaw is an adverse effect of bisphosphonates. While the etiopathogenesis of this condition has been investigated, the interactions and effects of bisphosphonates on oral mucosa cells remain unclear.
Fernanda Gonçalves BASSO   +6 more
doaj   +1 more source

Biometric, histomorphometric, and biochemical profile in atorvastatin calcium treatment of female rats with dexamethasone-induced osteoporosis

open access: yesRevista Brasileira de Ortopedia
Objective: To assess the effects of atorvastatin calcium in the treatment of dexamethasone-induced osteoporosis. Methods: Osteoporosis induction consisted of the administration of an intramuscular dose of 7.5 mg/kg of body weight of dexamethasone, once ...
Davilson Bragine Ferreira Junior   +5 more
doaj   +1 more source

In vitro study: binding of 99mTc-DPD to synthetic amyloid fibrils

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2015
This paper is an report of the investigation of the in vitro binding of 99mTc-DPD for synthetic amyloid fibrils used for the diagnosis of cardiac amyloidosis (CA), as compared with the use of 99mTc-HMDP and 99mTc-PPI. It also includes an inquiry into the
Buroni Federica E   +4 more
doaj   +1 more source

THE USE OF DIPHOSPHONATES IN MYELOMA [PDF]

open access: yesBritish Journal of Haematology, 1983
J A, Kanis, A D, Paterson, R G, Russell
openaire   +2 more sources

Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease

open access: yesCancer Pathogenesis and Therapy
This consensus on multiple myeloma-related bone diseases (MBDs) underscores the importance of a multidisciplinary approach that encompasses hematology, radiology, orthopedics, and additional specialties to tackle its intricate challenges.
Yutong Wang   +59 more
doaj   +1 more source

Anti-resorptive agents in neuroendocrine bone metastases – A systematic review

open access: yesJournal of Bone Oncology
Purpose: Bone metastases are common in patients with metastatic neuroendocrine neoplasms (NENs) and frequently result in skeletal complications. The current role of anti-resorptive agents for these patients is not known.
Marianne S. Elston   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy